SIRT1 and type 2 diabetes mellitus: Administering 40 mg and 500 mg for 6 months to type 2 diabetes mellitus patients increased Sirtuin-1 (Sirt1) expression which was associated with a decrease in H3K56 acetylation and body fat (Bo et al., 2018).